Rivaroxaban Impurity 55 | CAS 29518-11-4 - Request Quote
Rivaroxaban Impurity 55
| SZ CAT No: | SZ-R017091 |
| CAS No | 29518-11-4 |
| Mol.F. | C10H11NO2 |
| Mol.Wt. | 177.2 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rivaroxaban Impurity 55 is chemically 4-Phenylmorpholin-3-one. Rivaroxaban Impurity 55 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban Impurity 55 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 29518-11-4
Purchase 29518-11-4
Order 29518-11-4
Enquire 29518-11-4
price of 29518-11-4
29518-11-4 Supplier
29518-11-4 Manufacturer
29518-11-4 Exporter
buy high quality Rivaroxaban Impurity 55
Purchase Rivaroxaban Impurity 55
Rivaroxaban Impurity 55 suppliers
Rivaroxaban Impurity 55 manufacturers
Rivaroxaban Impurity 55 price
Order Rivaroxaban Impurity 55
Enquire Rivaroxaban Impurity 55
Rivaroxaban Impurity 55 cost
Rivaroxaban Impurity 55 Supplier
Rivaroxaban Impurity 55 Distributor
Rivaroxaban Impurity 55 for Method Validation
Rivaroxaban Reference Standard
Rivaroxaban Impurity 55 for ANDA Filing
Rivaroxaban Impurity 55 for Forced Degradation Studies
Rivaroxaban Impurity 55 Identification Standards
Rivaroxaban Impurity 55 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.